Clinical Trial Update: IG-VMAT for Localized Prostate Cancer [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial of IG-VMAT for localized prostate cancer, sponsored by Beijing Hospital. The current trial status is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• IG-VMAT

Snippet

Sponsor: Beijing Hospital | Conditions: Prostate Cancer | Phase 3 | Status: UNKNOWN